Capital Research and Management Increases Stake in KT&G to 8.2%

Capital Research and Management Company Increases Stake in KT&G

May 8, 2026

Financial Services

KT&G announced that Capital Research and Management Company acquired additional shares, raising its stake in KT&G from 5.61% to 7.21% for investment purposes. The disclosure is based on KT&G’s DART filings, showing Capital Research and Management Company holds 7.49 million shares as of the update.

Macquarie Asset Management to Acquire Remaining 50% Stake in TDC Group

May 9, 2025

Telecommunications

Macquarie Asset Management (MAM) has agreed to acquire an additional 50% stake in TDC Group from PFA, PKA and ATP, which will result in Macquarie managing 100% of the capital in TDC Group. The move secures full ownership to continue investments in Denmark’s digital infrastructure—completing fibre rollout, accelerating 5G coverage and furthering IT/cloud transformation and sustainability initiatives across TDC NET and Nuuday.

A&M Capital Partners Acquires Majority Stake in VTG

September 25, 2023

Aerospace & Defense

A&M Capital Partners has made a majority investment in VTG, a provider of modernization and digital transformation solutions for the U.S. Defense and Intelligence Community. The Jordan Company exited its ownership as part of the transaction; A&M plans to grow VTG via a mix of organic investments and acquisition-driven expansion.

Havencrest Capital Management Acquires Majority Stake in Tekton Research

September 7, 2023

Healthcare Services

Havencrest Capital Management has made a majority investment in Tekton Research, a multi-state clinical trial site network headquartered in Austin, Texas. The partnership will support Tekton’s expansion of investigator networks, improve clinical trial access for underrepresented communities, and accelerate growth into new sites and therapeutic areas.

Kohlberg Acquires Majority Stake in Worldwide Clinical Trials

August 7, 2023

Healthcare Services

An affiliate of Kohlberg & Company agreed to acquire a majority stake in Worldwide Clinical Trials, a global contract research organization (CRO) headquartered in Research Triangle Park, North Carolina. The transaction is a recapitalization in which prior investor TJC, L.P. retains a meaningful minority equity stake; terms were not disclosed. Kohlberg will partner with Worldwide's management (Matt Jennings to become chairman) to support continued growth of the company's clinical trial and bioanalytical capabilities.

Macquarie Asset Management Acquires DTG Recycle

December 1, 2022

Environmental Services

A fund managed by Macquarie Asset Management has completed the acquisition/recapitalization of DTG Recycle from Clairvest and other shareholders. DTG management (CEO Tom Vaughn and Chief Development Officer Dan Guimont) will retain ownership stakes and continue to run the business as MAM supports the company’s next stage of growth and geographic expansion across the Pacific Northwest.